Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs051190119
JPRN-jRCTs051190119
Active, not recruiting
未知

Assessment of global coagulation function under treatment of emicizumab concomitant with bypassing agents in hemophiliaA with inhibitor

ogami Keiji0 sites60 target enrollmentMarch 6, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHemophiliaA with Inhibitor

Overview

Phase
未知
Intervention
Not specified
Conditions
HemophiliaA with Inhibitor
Sponsor
ogami Keiji
Enrollment
60
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
ogami Keiji

Eligibility Criteria

Inclusion Criteria

  • •1\. Congenital Hemophilia A with inhibitors over 4 years old
  • •2\. Patients treated or planned for emicizumab base on the latest package insert
  • •3\. Patients with written consent has been obtained, explaining the content of this clinical study
  • •4\. Patients who can comply with the planned procedure in this clinical study

Exclusion Criteria

  • •1\. Patients who have difficulty in regular visits and/or visits at the event
  • •2\. Patients with other diseases with abnormal liver function or platelets
  • •3\. Patients who have difficulty collecting blood
  • •4\. Judged by the investigator to be inappropriate for some reasons

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
CAGUYAMA StudyHemophilia A without inhibitor
JPRN-jRCTs051210137ogami Keiji100
Completed
Not Applicable
Evaluation of reverence values of coagulation function measured by ROTEM in preterms”P61Other perinatal haematological disorders
DRKS00003972niversitätsklinik für Anästhesie, Allgmeine Intensivmedizin und Schmerztherapie142
Completed
Not Applicable
Assessment of coagulation profile using thromboelastographic parameters between cyanotic and non-cyanotic patients undergoing congenital cardiac surgeryDiseases of the circulatory system
KCT0001246Konkuk University Medical Center100
Completed
Not Applicable
the evaluation of coagulation function and platelet function after having stopped to use anti-platelet drug or anti-coagulant drug
JPRN-UMIN000017075Sapporo Medical University School of Medicine100
Completed
Not Applicable
Analysis of coagulability and coagulation factors before and after the development of symptoms in patients with physical urticariaphysical urticaria
JPRN-UMIN000002585Department of Dermatology, Hiroshima University Hospital20